IsoRay, Inc. (NYSEMKT: ISR)
IsoRay has had a great time in the market over the past few days. After announcing the launch of a new study that’s aimed at recurring head and neck cancers, investor excitement drove the stock up! So, naturally, I found myself following the trend. Looking at the stock today, it looks like another opportunity is poking it’s head out. In my opinion, it looks like we may have a breakout soon! So, we’ll take a look at it from a short term standpoint and talk about the breakout I think may come soon, and we’ll take a look at the stock from the long term standpoint to decide if the gains are likely to continue in the long run.
Technically, ISR Is Becoming A Beauty
Take a look at the chart to the left. It’s clear to see that support is climbing. Also, on May 6th, we started to see a flag in the chart; which was followed by breakout activity on May 7th. Now, we’re starting to see a flag in the chart yet again as the stock starts to meet heavy support. Based on what we’re seeing here, I think we can expect that more breakout activity is soon to come; which should drive the price of the stock even higher.
What Can We Expect To See Long Term
When it comes to long term predictions, I like to leave the charts out of it and start looking at fundamental data. With that said, it seems as though ISR is fundamentally sound. First off, the announcement of the study is big news to me. What we have to consider is the fact that cancer is a more than $100 billion per year industry; and IsoRay intends on taking their piece of the pie. Keeping in mind the start of the new study, the company will be working to improve survival rates in those that suffer from recurring head and neck cancers. In the likely case that their study proves to be effective in doing so, we can expect the value of this stock to climb dramatically. Overall, I’m excited for what we’re likely to see from ISR moving forward.
What Do You Think?
Where do you think ISR is headed and why? Let us know in the comments below.